Adult Congenital Heart Disease: Advances in Diagnosis, Surgery, and Lifelong Care

Dear Colleagues,

The number of patients with adult congenital heart disease (ACHD) is increasing. ACHD has several complications, such as arrhythmia, organ failure, heart failure, and protein-losing enteropathy. Pulmonary hypertension is one of the most serious complications. Recently, pulmonary hypertension-targeted drugs have been developed and survival is improving. However, for long-term survival in ACHD patients with pulmonary hypertension, there is still room for improvement. In this Topic, we focus on advanced diagnosis, surgery, and lifelong care in ACHD. In particular, pulmonary hypertension in ACHD is the main topic of this Topic.

Topics may include but are not limited to the following:

• Multi-omics analysis for the understanding of ACHD pathogenesis.
• Novel treatment strategies in patients with simple ACHD and complicated ACHD.
• Biomarkers for identifying the outcome of ACHD.
• Precision medicine strategies for patients with ACHD-PAH.
• Clinical implications of predicting survival and progression risk for patient management and outcome, including risk-adopted treatment strategies and quality of life measures.
• A multidisciplinary approach to the management of patients with ACHD.

We encourage the submission of both original research articles and reviews. All submitted articles will be considered for peer review.

Dr. Satoshi Akagi
Dr. Jin Young Song
Topic Editors